Ali S. Omrani

4.7k total citations · 3 hit papers
79 papers, 2.6k citations indexed

About

Ali S. Omrani is a scholar working on Infectious Diseases, Epidemiology and Molecular Medicine. According to data from OpenAlex, Ali S. Omrani has authored 79 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Infectious Diseases, 29 papers in Epidemiology and 19 papers in Molecular Medicine. Recurrent topics in Ali S. Omrani's work include SARS-CoV-2 and COVID-19 Research (20 papers), COVID-19 Clinical Research Studies (20 papers) and Antibiotic Resistance in Bacteria (19 papers). Ali S. Omrani is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (20 papers), COVID-19 Clinical Research Studies (20 papers) and Antibiotic Resistance in Bacteria (19 papers). Ali S. Omrani collaborates with scholars based in Saudi Arabia, Qatar and United States. Ali S. Omrani's co-authors include Ziad A. Memish, Ali Albarrak, Kamran Baig, Mustafa Saad, Jaffar A. Al‐Tawfiq, M. A. Matin, Sarah Shalhoub, Reem S. Almaghrabi, Muna Almaslamani and Mohammed Al Mutairi and has published in prestigious journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and BMJ.

In The Last Decade

Ali S. Omrani

76 papers receiving 2.5k citations

Hit Papers

Clinical aspects and outcomes of 70 patients with Middle ... 2014 2026 2018 2022 2014 2014 2015 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia
    2014 391 citations Mustafa Saad, Ali S. Omrani et al. International Journal of Infectious Diseases profile →
  2. Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study
    2014 381 citations Ali S. Omrani, Mustafa Saad et al. The Lancet Infectious Diseases profile →
  3. Viral Shedding and Antibody Response in 37 Patients With Middle East Respiratory Syndrome Coronavirus Infection
    2015 266 citations Ali Albarrak, Ali S. Omrani et al. profile →

Peers

Ali S. Omrani
Susan M. Poutanen Canada
Julien Poissy France
Saad Alhumaid Saudi Arabia
Satoshi Kutsuna Japan
Kyungmin Huh South Korea
Ilana Tal Israel
Alberto Enrico Maraolo Italy
Chang Kyung Kang South Korea
Pasquale Pagliano Italy
Barnaby Edward Young Singapore
Susan M. Poutanen Canada
Ali S. Omrani
Citations per year, relative to Ali S. Omrani Ali S. Omrani (= 1×) peers Susan M. Poutanen

Countries citing papers authored by Ali S. Omrani

Since Specialization
Citations

This map shows the geographic impact of Ali S. Omrani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali S. Omrani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali S. Omrani more than expected).

Fields of papers citing papers by Ali S. Omrani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali S. Omrani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali S. Omrani. The network helps show where Ali S. Omrani may publish in the future.

Co-authorship network of co-authors of Ali S. Omrani

This figure shows the co-authorship network connecting the top 25 collaborators of Ali S. Omrani. A scholar is included among the top collaborators of Ali S. Omrani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali S. Omrani. Ali S. Omrani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Omrani, Ali S., et al.. (2024). Cost-Efficient Subjective Task Annotation and Modeling through Few-Shot Annotator Adaptation. 3474–3491. 1 indexed citations
3.
Tsui, Clement K. M., et al.. (2024). Characterization of blaNDM in two Escherichia coli ST1193 clinical isolates in the Gulf region. JAC-Antimicrobial Resistance. 6(6). dlae166–dlae166. 1 indexed citations
4.
Saad, Mohamed, et al.. (2023). Characteristics and outcomes of adult patients with asthma presenting with COVID-19: A comparative cohort study. Qatar medical journal. 2023(3). 15–15. 1 indexed citations
5.
Tsui, Clement K. M., et al.. (2023). Genomic Epidemiology of Carbapenem-Resistant Klebsiella in Qatar: Emergence and Dissemination of Hypervirulent Klebsiella pneumoniae Sequence Type 383 Strains. Antimicrobial Agents and Chemotherapy. 67(7). e0003023–e0003023. 20 indexed citations
6.
Omrani, Ali S., et al.. (2022). Mycobacterium abscessus urinary tract infection in an immunocompetent host: A case report and literature review. IDCases. 29. e01538–e01538. 1 indexed citations
7.
Ibrahim, Emad Bashir, et al.. (2022). Epidemiology, microbiological and clinical characteristics of Enterococcus species bloodstream infections: A 10-year retrospective cohort study from Qatar. Annals of Medicine and Surgery. 80. 104258–104258. 8 indexed citations
8.
Omrani, Ali S. & Imad M. Tleyjeh. (2021). Which are the best coronavirus disease 2019 vaccines?. Clinical Microbiology and Infection. 27(12). 1729–1732. 1 indexed citations
9.
Almaghrabi, Reem S., et al.. (2021). Successful Use of Rifamycin-Sparing Regimens for the Treatment of Active Tuberculosis in Lung Transplant Recipients. Experimental and Clinical Transplantation. 19(4). 359–366. 2 indexed citations
10.
Almaslamani, Muna, et al.. (2020). Fatal Coronavirus Disease 2019-associated Pulmonary Aspergillosis; A Report of Two Cases and Review of the Literature. IDCases. 22. e00935–e00935. 19 indexed citations
11.
Almaghrabi, Reem S. & Ali S. Omrani. (2017). Middle East respiratory syndrome coronavirus (MERS-CoV) infection. British Journal of Hospital Medicine. 78(1). 23–26. 13 indexed citations
12.
Omrani, Ali S. & Reem S. Almaghrabi. (2017). Complications of hematopoietic stem transplantation. Hematology/Oncology and Stem Cell Therapy. 10(4). 239–244. 18 indexed citations
13.
Omrani, Ali S. & Reem S. Almaghrabi. (2017). Complications of hematopoietic stem cell transplantation. Hematology/Oncology and Stem Cell Therapy. 10(4). 228–232. 20 indexed citations
14.
Al‐Tawfiq, Jaffar A., Ali S. Omrani, & Ziad A. Memish. (2016). Middle East respiratory syndrome coronavirus: current situation and travel-associated concerns. PMC. 1 indexed citations
15.
Alikhani, Malihe, et al.. (2014). The Relationship between Human Capital and Learning Organization Components in Faculty Members of Imam-Khomeini Hospital Complex in 2011. scientific journal of ilam university of medical sciences. 21(7). 215–224.
16.
Omrani, Ali S., et al.. (2014). Analysis of Thraputic Expenditure in Patients with Multiple Sclerosis in Iran. scientific journal of ilam university of medical sciences. 21(7). 169–177. 3 indexed citations
17.
Saad, Mustafa, Ali S. Omrani, Kamran Baig, et al.. (2014). Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia. International Journal of Infectious Diseases. 29. 301–306. 391 indexed citations breakdown →
18.
19.
Omrani, Ali S., et al.. (2014). Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study. The Lancet Infectious Diseases. 14(11). 1090–1095. 381 indexed citations breakdown →
20.
Omrani, Ali S., et al.. (1999). BRONCHOGENIC CARCINOMA PRESENTING AS ABRONCHOPERICARDIAL FISTULA. International Journal of Clinical Practice. 53(2). 147–148. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan M. Poutanen Breakdown of academic impact, for papers by Julien Poissy Breakdown of academic impact, for papers by Saad Alhumaid Breakdown of academic impact, for papers by Satoshi Kutsuna Breakdown of academic impact, for papers by Kyungmin Huh Breakdown of academic impact, for papers by Ilana Tal Breakdown of academic impact, for papers by Alberto Enrico Maraolo Breakdown of academic impact, for papers by Chang Kyung Kang Breakdown of academic impact, for papers by Pasquale Pagliano Breakdown of academic impact, for papers by Barnaby Edward Young
Rankless by CCL
2026